Indivior Pharmaceuticals, Inc.
INDV
$36.76
-$1.07-2.83%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 252.00M | 210.00M | 129.00M | 108.00M | -7.00M |
| Total Depreciation and Amortization | 19.00M | 20.00M | 21.00M | 24.00M | 25.00M |
| Total Amortization of Deferred Charges | -- | -- | 3.00M | 3.00M | 3.00M |
| Total Other Non-Cash Items | 55.00M | 0.00 | 68.00M | 68.00M | 43.00M |
| Change in Net Operating Assets | -437.00M | -257.00M | -44.00M | 15.00M | 84.00M |
| Cash from Operations | -111.00M | -27.00M | 177.00M | 218.00M | 148.00M |
| Capital Expenditure | -81.00M | -66.00M | -58.00M | -45.00M | -32.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.00M | 0.00 | 24.00M | 66.00M | 71.00M |
| Cash from Investing | -80.00M | -66.00M | -34.00M | 21.00M | 39.00M |
| Total Debt Issued | 489.00M | -- | 332.00M | 332.00M | 332.00M |
| Total Debt Repaid | -346.00M | -17.00M | -250.00M | -247.00M | -243.00M |
| Issuance of Common Stock | 1.00M | 2.00M | 2.00M | 2.00M | 2.00M |
| Repurchase of Common Stock | -149.00M | -16.00M | -66.00M | -118.00M | -153.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.00M | 1.00M | -3.00M | -2.00M | -1.00M |
| Cash from Financing | -6.00M | -30.00M | 15.00M | -33.00M | -63.00M |
| Foreign Exchange rate Adjustments | -1.00M | -1.00M | 0.00 | 1.00M | 0.00 |
| Miscellaneous Cash Flow Adjustments | 1.00M | 0.00 | 0.00 | 1.00M | -- |
| Net Change in Cash | -197.00M | -124.00M | 158.00M | 208.00M | 124.00M |